HK175896A - Medicament for the treatment of cardiac insufficiency - Google Patents

Medicament for the treatment of cardiac insufficiency Download PDF

Info

Publication number
HK175896A
HK175896A HK175896A HK175896A HK175896A HK 175896 A HK175896 A HK 175896A HK 175896 A HK175896 A HK 175896A HK 175896 A HK175896 A HK 175896A HK 175896 A HK175896 A HK 175896A
Authority
HK
Hong Kong
Prior art keywords
group
carbon atoms
alkyl
groups
hydroxy
Prior art date
Application number
HK175896A
Other languages
German (de)
English (en)
French (fr)
Inventor
Rose Dr Peter
Original Assignee
Dr. Karl Thomae Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr. Karl Thomae Gmbh filed Critical Dr. Karl Thomae Gmbh
Publication of HK175896A publication Critical patent/HK175896A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Electrotherapy Devices (AREA)
  • External Artificial Organs (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
HK175896A 1987-10-30 1996-09-19 Medicament for the treatment of cardiac insufficiency HK175896A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873736866 DE3736866A1 (de) 1987-10-30 1987-10-30 Mittel zur behandlung des bluthochdrucks und der herzinsuffizienz

Publications (1)

Publication Number Publication Date
HK175896A true HK175896A (en) 1996-09-27

Family

ID=6339463

Family Applications (1)

Application Number Title Priority Date Filing Date
HK175896A HK175896A (en) 1987-10-30 1996-09-19 Medicament for the treatment of cardiac insufficiency

Country Status (11)

Country Link
US (1) US5516773A (enExample)
EP (2) EP0471388B1 (enExample)
JP (1) JP2665357B2 (enExample)
KR (1) KR960011240B1 (enExample)
AT (1) ATE91418T1 (enExample)
AU (1) AU607012B2 (enExample)
DE (2) DE3736866A1 (enExample)
DK (1) DK603688A (enExample)
HK (1) HK175896A (enExample)
HU (1) HU203282B (enExample)
ZA (1) ZA888090B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10018401A1 (de) 2000-04-13 2001-10-25 Boehringer Ingelheim Pharma Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen
US20040138306A1 (en) * 2002-07-25 2004-07-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
DE60200160T2 (de) * 2002-07-25 2004-11-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Cilobradine oder pharmazeutisch akzeptablen Salze zur Behandlung oder Prävention von Herzversagen
EP1762179A1 (en) * 2005-09-07 2007-03-14 Boehringer Ingelheim Vetmedica Gmbh Method for improving diagnostic quality in echocardiography
FR2894825B1 (fr) * 2005-12-21 2010-12-03 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent
KR20140057604A (ko) 2011-08-12 2014-05-13 베링거잉겔하임베트메디카게엠베하 고양잇과 동물의 심부전을 치료 및 예방하는 방법에 사용하기 위한 퍼니 전류 억제제
WO2014122248A1 (en) 2013-02-11 2014-08-14 Boehringer Ingelheim Vetmedica Gmbh Kit-of-parts

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2639718C2 (de) * 1976-09-03 1987-03-05 Dr. Karl Thomae Gmbh, 7950 Biberach 1-[6,7-Dimethoxy-3,4-dihydro-2H-isochinolin-1-on-2-yl]-3-[N-methyl-N-(2-(3,4-dimethoxy-phenyl)-äthyl)-amino]-propan, dessen physiologisch verträgliche Säureadditionssalze und diese Verbindungen enthaltende Arzneimittel
US4490369A (en) * 1981-05-19 1984-12-25 Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung Benzazepine derivatives, their pharmaceutical compositions and method of use
DE3119874A1 (de) * 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"

Also Published As

Publication number Publication date
EP0471388B1 (de) 1993-07-14
EP0471388A2 (de) 1992-02-19
ATE91418T1 (de) 1993-07-15
AU2443888A (en) 1989-05-04
DE3882381D1 (enExample) 1993-08-19
JP2665357B2 (ja) 1997-10-22
EP0313945A3 (de) 1990-12-05
HU203282B (en) 1991-07-29
DE3736866A1 (de) 1989-05-11
DK603688A (da) 1989-05-01
EP0471388A3 (de) 1992-03-11
DK603688D0 (da) 1988-10-28
KR960011240B1 (ko) 1996-08-21
US5516773A (en) 1996-05-14
EP0313945A2 (de) 1989-05-03
JPH02138123A (ja) 1990-05-28
AU607012B2 (en) 1991-02-21
HUT48464A (en) 1989-06-28
ZA888090B (en) 1990-07-25
KR890006234A (ko) 1989-06-12

Similar Documents

Publication Publication Date Title
EA014707B1 (ru) Новая форма введения рацекадотрила
PL197545B1 (pl) Sposób wytwarzania preparatu farmaceutycznego, zawierającego jako substancję czynną tolperyzon lub jego sól, do podawania doustnego, o przedłużonym uwalnianiu substancji czynnej
HU228387B1 (en) Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and pharmaceutical compositions containing them
EP0306846A2 (de) Neue synergistische Kombination bestehend aus einem Phosphodiesterase-Hemmer und einem Thromboxan-A2-Antagonisten und deren Verwendung bzw. Herstellung
CA2656270A1 (en) Solid dose formulations of a thrombin receptor antagonist
EP0471388B1 (de) Mittel zur Behandlung der Herzinsuffizienz
JPS5940134B2 (ja) 抗血栓性医薬組成物
US4042697A (en) Isoquinolium compounds for treating diabetes
US4088778A (en) Method for the treatment of hypertension
US4617306A (en) Pharmaceutical preparation comprising co-dergocrine and a calcium antagonist
US3462534A (en) Production of an antidepressant effect with esters of gallic acid
CN101899056A (zh) 普拉格雷氢溴酸盐多晶型物及其制备方法
CZ281691B6 (cs) Farmaceutický prostředek proti vysokému krevnímu tlaku
EP0260527B1 (de) Neue synergistische Kombination bestehend aus einem Phosphodiesterase-Hemmer und einem Tromboxan-A2-Antagonisten und deren Verwendung bzw. Herstellung
JP3535207B2 (ja) 抗ガン剤及びｇｒｐレセプター拮抗剤
US3140229A (en) Laxative compositions containing (4, 4'-dihydroxy-2''-amino)-triphenylmethane and method of using same
WO1997042945A1 (en) Oral pharmaceutical compositions
US3642993A (en) Pharmaceutical composition containing 2-methyl - 5 - phenyl - 1 2-dihydro-3h-2-benzazepine for treatment of a condition associated with anxiety or tension
CS276842B6 (en) Pharmaceutical
US4614743A (en) Methods of treating pain and inflammation with 4,7-dimethyl-2-(4-pyridinyl)-1,2,4,-triazolo[1,5-a]pyrimidin-5(4H)-one or the pharmaceutically acceptable salts or solvates thereof
AT393962B (de) Synergistische arzneimittelkombination mit einem gehalt an einem phosphodiesterase-hemmer und derenverwendung
CS207455B2 (en) Method of preparation of the new therapeutic mixture
US3784695A (en) Production of an hypotensive effect with esters of gallic acid
NO772339L (no) Substituerte triazoler.
JPS5852286A (ja) 新規なジヒドロピリジン化合物

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)